Inovio Pharmaceuticals Stock Target Price and Analyst Consensus

INO Stock  USD 13.03  0.65  5.25%   
The current analyst and expert consensus on Inovio Pharmaceuticals is Buy, with 1 strong buy opinions. The current projected Inovio Pharmaceuticals target price consensus is 1.25 with 5 analyst opinions. The most common way Inovio Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Inovio Pharmaceuticals executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Inovio Pharmaceuticals. We strongly encourage you to use your own analysis of Inovio Pharmaceuticals to validate this buy or sell advice. Inovio Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Inovio Pharmaceuticals target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Inovio Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
Lowest Forecast
1.14
Highest Forecast
1.39
Target Price
1.25
As of the 28th of March 2024, Gross Profit is likely to grow to about (2.5 M). In addition to that, Pretax Profit Margin is likely to grow to -154.28. At this time, Inovio Pharmaceuticals' Property Plant And Equipment Gross is very stable compared to the past year. As of the 28th of March 2024, Other Current Liabilities is likely to grow to about 19.7 M, while Total Assets are likely to drop about 131.1 M.
  
It's important to approach Inovio Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Inovio Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inovio target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Inovio Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   5  Buy
Most Inovio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Inovio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Inovio Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Inovio Pharmaceuticals Target Price Projection

Inovio Pharmaceuticals' current and average target prices are 13.03 and 1.25, respectively. The current price of Inovio Pharmaceuticals is the price at which Inovio Pharmaceuticals is currently trading. On the other hand, Inovio Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Inovio Pharmaceuticals Market Quote on 28th of March 2024

Low Price12.34Odds
High Price13.15Odds

13.03

Target Price

Analyst Consensus On Inovio Pharmaceuticals Target Price

Low Estimate1.14Odds
High Estimate1.39Odds

1.25

Historical Lowest Forecast  1.14 Target Price  1.25 Highest Forecast  1.39
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Inovio Pharmaceuticals and the information provided on this page.

Inovio Pharmaceuticals Analyst Ratings

Inovio Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Inovio Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Inovio Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Inovio Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Inovio Pharmaceuticals price targets

Inovio Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Inovio Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Inovio Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Inovio Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Inovio Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Inovio Pharmaceuticals is a key component of Inovio Pharmaceuticals valuation and have some predictive power on the future returns of a Inovio Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Inovio Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
4.4512.1919.93
Details
Intrinsic
Valuation
LowRealHigh
0.306.0213.76
Details
Naive
Forecast
LowNextHigh
6.6214.3622.10
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.17-0.99-0.86
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inovio Pharmaceuticals. Your research has to be compared to or analyzed against Inovio Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Inovio Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Inovio Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested a lot of shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Business Services Idea
Business Services
Invested few shares
Momentum Idea
Momentum
Invested over 40 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock:
Check out Macroaxis Advice on Inovio Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Inovio Stock analysis

When running Inovio Pharmaceuticals' price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
The data published in Inovio Pharmaceuticals' official financial statements usually reflect Inovio Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Inovio Pharmaceuticals. For example, before you start analyzing numbers published by Inovio accountants, it's critical to develop an understanding of what Inovio Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Inovio Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inovio Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Inovio Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Inovio Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Inovio Pharmaceuticals' management manipulating its earnings.